Skip to main navigation Skip to search Skip to main content

A Multi-Center, Randomized, Double-Blind, Study Evaluating the Efficacy, Safety and Tolerability of 20mg/kg Dose of RO4905417 Administered Every Four Weeks for 32 Weeks in Patients Undergoing Coronary Artery Bypass Graft Surgery (CABG)

Project: Research

Project Details

StatusFinished
Effective start/end date06/8/1102/28/13

Funding

  • Hoffmann Laroche Incorporated: $7,375.00